APA

Anderson J. J., Rao S. P., Rowe B., Giracello D. R., Holtz G., Chapman D. F., Tehrani L., Bradbury M. J., Cosford N. D. P. & Varney M. A. (20021224). [3H]Methoxymethyl-3-[(2-methyl-1,3-thiazol-4-yl)ethynyl]pyridine binding to metabotropic glutamate receptor subtype 5 in rodent brain: in vitro and in vivo characterization. : The Journal of pharmacology and experimental therapeutics.

Chicago

Anderson Jeffery J, Rao Sara P, Rowe Blake, Giracello Darlene R, Holtz Greg, Chapman Deborah F, Tehrani Lida, Bradbury Margaret J, Cosford Nicholas D P and Varney Mark A. 20021224. [3H]Methoxymethyl-3-[(2-methyl-1,3-thiazol-4-yl)ethynyl]pyridine binding to metabotropic glutamate receptor subtype 5 in rodent brain: in vitro and in vivo characterization. : The Journal of pharmacology and experimental therapeutics.

Harvard

Anderson J. J., Rao S. P., Rowe B., Giracello D. R., Holtz G., Chapman D. F., Tehrani L., Bradbury M. J., Cosford N. D. P. and Varney M. A. (20021224). [3H]Methoxymethyl-3-[(2-methyl-1,3-thiazol-4-yl)ethynyl]pyridine binding to metabotropic glutamate receptor subtype 5 in rodent brain: in vitro and in vivo characterization. : The Journal of pharmacology and experimental therapeutics.

MLA

Anderson Jeffery J, Rao Sara P, Rowe Blake, Giracello Darlene R, Holtz Greg, Chapman Deborah F, Tehrani Lida, Bradbury Margaret J, Cosford Nicholas D P and Varney Mark A. [3H]Methoxymethyl-3-[(2-methyl-1,3-thiazol-4-yl)ethynyl]pyridine binding to metabotropic glutamate receptor subtype 5 in rodent brain: in vitro and in vivo characterization. : The Journal of pharmacology and experimental therapeutics. 20021224.